Director, Field Learning & Development
Listed on 2026-02-01
-
Management
Director, Field Learning & Development
About Summit Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people.
Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence.
Location
:
Princeton, NJ (ONSITE)
The Director, Field Learning & Development (FL&D), is responsible for leading the strategy, development, and execution of training programs for field sales teams and other field‑facing commercial functions as needed. The Director FL&D responsibilities include delivery of curriculum for new hire training, brand updates, selling skills, new product launches, POA and National Sales Meetings. This role works closely with senior brand leaders to ensure alignment with brand strategy and brand messaging.
Additionally, they will work with Sales Leadership to ensure alignment and effectiveness of training programs that support national, area and regional training needs.
- Oversee end‑to‑end training curriculum, including new hire onboarding, disease‑state/clinical content, competitive intelligence, advanced selling capabilities, and ongoing development programs
- Lead the design, development, and deployment of innovative training solutions (in‑person, virtual, digital, and blended learning)
- Build frameworks that support product launches, market expansion, and evolving oncology/biotech treatment landscapes
- Partner with Sales, Marketing, Medical Affairs, Market Access and Commercial Operations to ensure all training programs reinforce brand strategy, scientific accuracy, and compliance requirements
- Lead new hire brand training curriculum design, build, implementation
- Partner with senior brand leaders to ensure curriculum alignment
- Ensure all training content adheres to company policies, regulatory requirements, and industry standards
- Partner with senior sales leaders to ensure training effectiveness
- Lead training in tactical and budget planning process for all therapeutic areas
- Ensure field team effectiveness in new hire training responsibilities
- Continuously evaluate FL&D learning curricula across brands to ensure effectiveness
- Lead special projects including development and implementation of selling model, competency model and new hire curriculum
- All other duties as assigned
- Bachelor’s degree required
- Minimum of 10+ years of relevant experience in biotech or pharmaceutical industry, including:
- Minimum of 3+ years of pharmaceutical sales experience
- Minimum of 5+ years of Commercial Learning leadership experience
- Proven track record leading commercial training, field development, or sales effectiveness initiatives
- Experience in oncology/hematology
- Strong leadership experience in oncology (lung cancer preferred) training including curriculum design and delivery
- Strong understanding of clinical/scientific concepts, competitive landscapes, and oncology treatment paradigms
- Demonstrated ability to lead teams, influence senior leaders, and manage complex cross‑functional initiatives
- Exceptional communication, facilitation, and strategic planning skills
- Demonstrated people leadership experience managing various levels of learning professionals
Pay range for this role is $190,000–$237,000 annually. Actual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location.
Clinical Studies in Oncology Non‑Small Cell Lung Cancer (NSCLC)- HARMONi:
Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR‑mutated, locally advanced or metastatic…
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).